P. Corthésy

发表

Clonotype Selection and Composition of Human CD8 T Cells Specific for Persistent Herpes Viruses Varies with Differentiation but Is Stable Over Time1

D. Speiser, Emanuela M. Iancu, P. Corthésy, 2009, The Journal of Immunology.

De novo protein design enables precise induction of functional antibodies in vivo

B. Correia, P. Corthésy, J. Bates, 2020 .

Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen

S. Reddy, P. Gainza, B. Correia, 2018, bioRxiv.

Trivalent cocktail of de novo designed immunogens enables the robust induction and focusing of functional antibodies in vivo

Y. Li, P. Corthésy, X. Wen, 2019, bioRxiv.

Boosting subdominant neutralizing antibody responses with a computationally designed epitope-focused immunogen

P. Gainza, P. Corthésy, M. Chen, 2018, bioRxiv.

Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts.

D. Paterson, W. Jefferies, M. Brandon, 1987, Molecular immunology.

Lymphocytes T + Human Effector-Memory CD 8 Four Functionally Distinct Populations of Rufer

D. Speiser, P. Corthésy, Estelle Devêvre, 2007 .

Identification of swiprosin 1 in human lymphocytes

P. Corthésy, N. Rufer, J. Tissot, 2004, Proteomics.

Interleukin 2 receptor traffic in a murine cytolytic T cell line

J. Lowenthal, P. Corthésy, M. Nabholz, 1987, European journal of immunology.

Characterization of soluble factors that induce the cytolytic activity and the expression of T cell growth factor receptors of a T cell hybrid

W. Fiers, P. Corthésy, K. Smith, 1984, The Journal of experimental medicine.

Interleukin 2 is both necessary and sufficient for the growth and differentiation of lectin-stimulated cytolytic T lymphocyte precursors.

J. Lowenthal, P. Corthésy, H. Macdonald, 1985, Journal of immunology.

replicative history and partial effector functions Ex vivo characterization of human CD8+ T subsets with distinct

P. Corthésy, M. Pittet, S. Leyvraz, 2013 .

A Novel Approach to Characterize Clonality and Differentiation of Human Melanoma-Specific T Cell Responses: Spontaneous Priming and Efficient Boosting by Vaccination1

D. Speiser, P. Corthésy, P. Baumgaertner, 2006, The Journal of Immunology.

Mouse interleukin-2 receptor alpha gene expression. Delimitation of cis-acting regulatory elements in transgenic mice and by mapping of DNase-I hypersensitive sites.

P. Corthésy, H. Macdonald, M. Pla, 1995, The Journal of biological chemistry.

Appearance of cytolytic granules upon induction of cytolytic activity in CTL‐hybrids.

J. Tschopp, P. Corthésy, M. Nabholz, 1985, The EMBO journal.

Constitutive Expression of a Chimeric Receptor That Delivers IL-2/IL-15 Signals Allows Antigen-Independent Proliferation of CD8+CD44high But Not Other T Cells1

P. Corthésy, H. Macdonald, S. Gasser, 2000, The Journal of Immunology.

Interleukin 1 and tumor necrosis factor enhance transcription from the SV40 early promoter in a T cell line

P. Corthésy, G. Plaetinck, M. Nabholz, 1989, European journal of immunology.

Mouse interleukin-2 receptor alpha gene expression. Interleukin-1 and interleukin-2 control transcription via distinct cis-acting elements.

P. Bucher, P. Corthésy, M. Pla, 1995, The Journal of biological chemistry.

Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients

M. Swartz, L. Santambrogio, D. Speiser, 2019, The Journal of experimental medicine.

Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes

J. Hubbell, M. Swartz, P. Corthésy, 2014, Cancer Immunology Research.

Rat × Mouse T‐cell Hybrids with Inducible Specific Cytolytic Activity

P. Corthésy, H. Macdonald, A. Silva, 1983, Immunological reviews.

CYTOLYTIC HYBRIDS BETWEEN MURINE CTL-LINES AND MOUSE OR RAT THYMOMAS

P. Corthésy, Augusto Silva, M. Nabholz, 1982 .

High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61.

J. Lowenthal, P. Corthésy, H. Macdonald, 1985, Journal of immunology.

Four Functionally Distinct Populations of Human Effector-Memory CD8+ T Lymphocytes1

Pedro Romero, Daniel E. Speiser, Nathalie Rufer, 2007, The Journal of Immunology.

Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functions.

P. Corthésy, P. Romero, N. Rufer, 2003, Blood.

Hybrids between rat lymphoma and mouse T cells with inducible cytolytic activity

P. Corthésy, Augusto Silva, M. Nabholz, 1982, Nature.

Mouse Interleukin-2 Receptor Gene Expression

P. Bucher, P. Corthésy, S. Wang, 1995, Journal of Biological Chemistry.

Fine Structural Variations of αβTCRs Selected by Vaccination with Natural versus Altered Self-Antigen in Melanoma Patients1

D. Speiser, P. Corthésy, P. Baumgaertner, 2009, The Journal of Immunology.

17 – Correlation between Cytolytic Activity, Growth Factor Dependence, and Lectin Resistance in Cytolytic T Cell Hybrids

P. Corthésy, M. Nabholz, A. Conzelmann, 1982 .

by Vaccination Spontaneous Priming and Efficient Boosting Melanoma-Specific T Cell Responses: and Differentiation of Human A Novel Approach to Characterize Clonality

D. Speiser, P. Corthésy, P. Baumgaertner, 2006 .

A Conserved IL-2 Responsive Enhancer in the IL-2Rα Gene

P. Bucher, P. Corthésy, J. Imbert, 1997 .

Control of IL-2 receptor-alpha expression by IL-1, tumor necrosis factor, and IL-2. Complex regulation via elements in the 5' flanking region.

T. Honjo, P. Corthésy, G. Plaetinck, 1990, Journal of immunology.

De novo protein design enables the precise induction of RSV-neutralizing antibodies

Luciano A. Abriata, John T. Bates, Bruno E. Correia, 2020, Science.

Dominant Human CD8 T Cell Clonotypes Persist Simultaneously as Memory and Effector Cells in Memory Phase1

D. Speiser, P. Corthésy, P. Romero, 2009, The Journal of Immunology.

In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration1

H. Pircher, D. Speiser, P. Corthésy, 2007, The Journal of Immunology.